Stock & Company Details
AnaptysBio Inc $ANAB
Price:
N/A
N/A
30M
$1.7B
52 Week High:
N/A
10 Day Average Volume:
N/A
-64.17
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ANAB technical indicators
Latest AnaptysBio Inc (ANAB) indicator readings as of 2026-08-28.
ANAB's 14-day RSI is 47.0, in neutral territory. At $56.28 it is trading 2.6% above its 200-day moving average of $54.88, and below its 50-day average of $58.43. Price sits in the middle of its Bollinger Bands ($53.80 to $60.28). ADX reads 11.3, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
AnaptysBio Inc is a clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonists. The entity generates revenue from collaborative research and development arrangements.
Finance Bot
Ask your questions
Start by typing a question below.
